INVA

Innoviva

• Simply Wall St·11h ago

  Innoviva (INVA) Back In Focus On Royalty Narrative And $35 Fair Value View

• NASDAQ·17h ago

  INVA vs. MRK: Which Stock Is the Better Value Option?

• NASDAQ·19h ago

  Should Value Investors Buy Innoviva (INVA) Stock?

• TipRanks·09/30 09:56

  Oppenheimer Names 2 Stocks to Buy for the Rest of 2026

• Simply Wall St·09/29 21:19

  Innoviva (INVA) Could Be 40% Undervalued If Its Royalty Story Holds

• Dow Jones·09/23 12:23

  Innoviva Price Target Announced at $35.00/Share by Oppenheimer

• Dow Jones·09/23 12:23

  Innoviva Coverage Assumed by Oppenheimer at Outperform

• Benzinga·09/23 12:13

  Oppenheimer Assumes Innoviva at Outperform, Announces Price Target of $35

• TipRanks·09/23 11:00

  Innoviva assumed with an Outperform at Oppenheimer

• Simply Wall St·09/13 17:20

  Is Innoviva (INVA) A Bargain As Conference Appearances Put Valuation Back In Focus?

• Seeking Alpha·09/08 14:00

  Stock Picks From Seeking Alpha's August 2026 New Analysts

• Simply Wall St·08/26 15:30

  Innoviva (INVA) Faces A Valuation Test, Is The Discount Too Wide?

• TipRanks·08/21 12:30

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Innoviva (INVA) and Pfizer (PFE)

• TipRanks·08/17 08:41

  Innoviva management to meet virtually with Cantor Fitzgerald

• Simply Wall St·08/16 18:20

  Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA)